-

Polestar Automotive Holding UK PLC (PSNY) Shareholder Investigation: Robbins LLP is Investigating Polestar Automotive Holding UK PLC on behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Polestar Automotive Holding UK PLC (NASDAQ: PSNY) to determine whether certain Polestar officers and directors violated securities laws and breached fiduciary duties to shareholders by engaging in a conflicted SPAC process. In June 2022, special purpose acquisition company Gores Guggenheim Inc. completed the acquisition of Polestar, which began trading as PSNY on June 24, 2022. On the first day of trading, Polestar shares reached $13.00 per share. Today, the shares trade around $3.50 per share.

What Now: Polestar Automotive Holding UK PLC shareholders have legal options. If you own shares of Polestar or have incurred a significant loss in the stock, contact us for more information about your rights.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Polestar Automotive Holding UK PLC settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:PSNY

Release Summary
Robbins LLP is Investigating Polestar Automotive Holding UK PLC (PSNY) on behalf of Shareholders
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Regeneron Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Regeneron Therapeutics, Inc. (NASDAQ: REGN) from August 1, 2025 to May 15, 2026. Regeneron is a pharmaceutical company that discovers, invents, develops, manufactures, tests, and commercializes medicines to treat various disorders worldwide.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The...

Badger Meter, Inc. Class Action Reminder – Robbins LLP Encourages BMI Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Badger Meter, Inc. (NYSE: BMI) common stock between April 18, 2024 and April 16, 2026. Badger Meter manufactures and sells water measurement and management products.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.What is the class period? April 18, 2024 - April 16, 2026What are the alleg...

Verra Mobility Corporation Stock Drop - Robbins LLP Urges VRRM Investors to Contact the Firm for Information About Recovering Their Losses  

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Verra Mobility Corporation (NASDAQ: VRRM) securities between February 24, 2026, and May 26, 2026. Verra Mobility Corporation provides smart mobility technology solutions in the United States, Australia, Europe, and Canada. It operates through three segments: Commercial Services, Government Solutions, and Parking Solutions.For more information,...
Back to Newsroom